var data={"title":"Visceral leishmaniasis: Epidemiology and control","body":"<div id=\"topicContent\" class=\"utdArticleSection utdStyle\"><div id=\"topicTitle\">Visceral leishmaniasis: Epidemiology and control</div><dl id=\"topicContributors\"><dt><span> </span>Author:</dt><dd><a href=\"https://www.uptodate.com/contents/visceral-leishmaniasis-epidemiology-and-control/contributors\" class=\"contributor contributor_credentials\">Caryn Bern, MD, MPH</a></dd><dt><span> </span>Section Editor:</dt><dd><a href=\"https://www.uptodate.com/contents/visceral-leishmaniasis-epidemiology-and-control/contributors\" class=\"contributor contributor_credentials\">Peter F Weller, MD, MACP</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a href=\"https://www.uptodate.com/contents/visceral-leishmaniasis-epidemiology-and-control/contributors\" class=\"contributor contributor_credentials\">Elinor L Baron, MD, DTMH</a></dd></dl><p class=\"disclosureLink\"><a href=\"https://www.uptodate.com/contents/visceral-leishmaniasis-epidemiology-and-control/contributor-disclosure\" class=\"contributor contributor_credentials\">Contributor Disclosures</a></p><div id=\"reviewProcess\"><span>All topics are updated as new evidence becomes available and our <a href=\"https://www.uptodate.com/home/editorial-policy\" target=\"_blank\" class=\"policy policy_editorialpolicy\">peer review process</a> is complete.</span></div><div id=\"literatureReviewDate\"><span class=\"emphasis\">Literature review current through:</span>&#160;Feb 2018.&#160;&#124;&#160;<span class=\"emphasis\">This topic last updated:</span>&#160;Jul 25, 2017.</div><div id=\"topicWhatsNewContainer\"></div><div id=\"topicText\"><p class=\"headingAnchor\" id=\"H1\"><span class=\"h1\">INTRODUCTION</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Leishmaniasis consists of a complex of vector-borne diseases caused by more than 20 species of the protozoan genus <em>Leishmania</em> and is transmitted by sand fly vectors (<a href=\"image.htm?imageKey=ID%2F58861\" class=\"graphic graphic_table graphicRef58861 \">table 1</a>) [<a href=\"https://www.uptodate.com/contents/visceral-leishmaniasis-epidemiology-and-control/abstract/1,2\" class=\"abstract_t\">1,2</a>]. Clinical manifestations range from cutaneous ulcers to systemic multiorgan disease. Visceral leishmaniasis (VL) is caused primarily by the two related species <em>Leishmania donovani</em> and <em>Leishmania infantum</em> (synonym <em>Leishmania chagasi</em>).</p><p>An estimated 200,000 to 400,000 new VL cases and 20,000 to 40,000 deaths from VL occur each year [<a href=\"https://www.uptodate.com/contents/visceral-leishmaniasis-epidemiology-and-control/abstract/3,4\" class=\"abstract_t\">3,4</a>]. Among tropical diseases, leishmaniasis ranks second in mortality and fourth in loss of disability-adjusted life years (DALYs) [<a href=\"https://www.uptodate.com/contents/visceral-leishmaniasis-epidemiology-and-control/abstract/5\" class=\"abstract_t\">5</a>]. Leishmaniasis is considered one of the &quot;most neglected diseases&quot; given its strong association with poverty and the limited resources invested in new tools for diagnosis, treatment, and control [<a href=\"https://www.uptodate.com/contents/visceral-leishmaniasis-epidemiology-and-control/abstract/6,7\" class=\"abstract_t\">6,7</a>].</p><p>Issues related to epidemiology and control are discussed here. Issues related to clinical manifestations, diagnosis, and treatment are discussed separately. (See <a href=\"topic.htm?path=visceral-leishmaniasis-clinical-manifestations-and-diagnosis\" class=\"medical medical_review\">&quot;Visceral leishmaniasis: Clinical manifestations and diagnosis&quot;</a> and <a href=\"topic.htm?path=visceral-leishmaniasis-treatment\" class=\"medical medical_review\">&quot;Visceral leishmaniasis: Treatment&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H2\"><span class=\"h1\">EPIDEMIOLOGY</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The epidemiology and ecology of visceral leishmaniasis (VL) in a particular region are determined by characteristics of the parasite species, sand fly species, and mammalian reservoir host(s) (<a href=\"image.htm?imageKey=ID%2F110870\" class=\"graphic graphic_figure graphicRef110870 \">figure 1</a>). In all major endemic areas, asymptomatic infections (measured by seroconversion <span class=\"nowrap\">and/or</span> leishmanin skin testing) outnumber clinically manifest disease [<a href=\"https://www.uptodate.com/contents/visceral-leishmaniasis-epidemiology-and-control/abstract/8-11\" class=\"abstract_t\">8-11</a>]. Seroconversion reflects newly acquired infection but may precede onset of clinical VL by months [<a href=\"https://www.uptodate.com/contents/visceral-leishmaniasis-epidemiology-and-control/abstract/9,10\" class=\"abstract_t\">9,10</a>].</p><p>The best measure of protective immunity is the leishmanin skin test (LST), which reflects durable but probably not permanent cell-mediated immunity. Individuals with positive LST have more than 95 percent reduced risk of VL compared with those with negative LST, and the age-related rise in positive LST prevalence in a community parallels the age-related decrease in disease risk [<a href=\"https://www.uptodate.com/contents/visceral-leishmaniasis-epidemiology-and-control/abstract/11-14\" class=\"abstract_t\">11-14</a>]. A parallel fall in the average age of VL patients may be observed as an epidemic matures [<a href=\"https://www.uptodate.com/contents/visceral-leishmaniasis-epidemiology-and-control/abstract/15\" class=\"abstract_t\">15</a>]. Factors that increase the likelihood an individual will progress from leishmanial infection to clinical VL include poor nutritional status, age &lt;5 years (for <em>L. infantum </em>infection), HIV coinfection, and host immunogenetic factors [<a href=\"https://www.uptodate.com/contents/visceral-leishmaniasis-epidemiology-and-control/abstract/13,16-20\" class=\"abstract_t\">13,16-20</a>].</p><p class=\"headingAnchor\" id=\"H3\"><span class=\"h2\">Species</span></p><p class=\"headingAnchor\" id=\"H4\"><span class=\"h3\">L. donovani</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Visceral leishmaniasis due <em>to L. donovani</em> occurs in South Asia (India, Bangladesh, and Nepal) and East Africa (Sudan, Ethiopia, Kenya, and Somalia). Clinical disease due to <em>L. donovani</em> can affect individuals of all ages, although, in regions with sustained endemic transmission, the incidence may fall with increasing age because of a high rate of acquired immunity in adults [<a href=\"https://www.uptodate.com/contents/visceral-leishmaniasis-epidemiology-and-control/abstract/1,12\" class=\"abstract_t\">1,12</a>].</p><p>In both the Indian subcontinent and East Africa, VL tends to occur in epidemic cycles; the incidence rises over a period of 2 to 5 years, peaks, and then falls, only to rise again after a 5- to 10-year period of low incidence [<a href=\"https://www.uptodate.com/contents/visceral-leishmaniasis-epidemiology-and-control/abstract/21,22\" class=\"abstract_t\">21,22</a>]. In 2014, India and Bangladesh together reported approximately 10,000 VL cases, while Sudan, South Sudan, and Ethiopia together reported more than 14,000 cases [<a href=\"https://www.uptodate.com/contents/visceral-leishmaniasis-epidemiology-and-control/abstract/21\" class=\"abstract_t\">21</a>]. The true case load is likely substantially higher.</p><p>In the Indian subcontinent, efforts to eliminate VL as a public health problem have been underway since 2005. Areas of emphasis have included improving timeliness of diagnosis and treatment as well as vector control through residual household insecticide application. The incidence of VL in the focus of <em>L. donovani</em> transmission straddling northeastern India, southeastern Nepal, and Bangladesh has fallen markedly between 2005 to 2014 [<a href=\"https://www.uptodate.com/contents/visceral-leishmaniasis-epidemiology-and-control/abstract/4,21\" class=\"abstract_t\">4,21</a>]. In this area of transmission, humans are the only proven reservoir host [<a href=\"https://www.uptodate.com/contents/visceral-leishmaniasis-epidemiology-and-control/abstract/1,23,24\" class=\"abstract_t\">1,23,24</a>].</p><p>In East Africa, transmission of <em>L. donovani</em> consists of both anthroponotic and zoonotic components. In Sudan, sylvatic rodents and domestic dogs may act as reservoirs; however, large human VL outbreaks in villages and refugee settings are thought to reflect predominantly anthroponotic transmission [<a href=\"https://www.uptodate.com/contents/visceral-leishmaniasis-epidemiology-and-control/abstract/15,25-29\" class=\"abstract_t\">15,25-29</a>].</p><p class=\"headingAnchor\" id=\"H5\"><span class=\"h3\">L. infantum</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>VL due to <em>L. infantum</em> (synonym <em>L. chagasi</em>) occurs in the Mediterranean (including Spain, France, and Greece), the Middle East, Afghanistan, Iran, Pakistan, and Brazil. In addition, sporadic cases have been reported in Central Asia, China, Mexico, and Central and Latin America outside of Brazil [<a href=\"https://www.uptodate.com/contents/visceral-leishmaniasis-epidemiology-and-control/abstract/2,23\" class=\"abstract_t\">2,23</a>]. The highest case load in 2014 was reported from Brazil with 3453 cases [<a href=\"https://www.uptodate.com/contents/visceral-leishmaniasis-epidemiology-and-control/abstract/21\" class=\"abstract_t\">21</a>]. All other <em>L. infantum</em>&ndash;endemic countries reported fewer than 300 cases.</p><p>Children &lt;10 years and immunosuppressed adults have a higher risk of clinical disease due to <em>L. infantum</em> than immunocompetent adults [<a href=\"https://www.uptodate.com/contents/visceral-leishmaniasis-epidemiology-and-control/abstract/30-32\" class=\"abstract_t\">30-32</a>]. The predominance of pediatric <em>L. infantum</em> cases may be related to several factors including lower parasite virulence than <em>L. donovani</em>, the immature innate immune response, lack of prior exposure and acquired immunity, and higher rates of malnutrition among children than adults [<a href=\"https://www.uptodate.com/contents/visceral-leishmaniasis-epidemiology-and-control/abstract/11,16,33\" class=\"abstract_t\">11,16,33</a>]. The lower incidence of <em>L. infantum</em> among adults in endemic areas may be due in part to prior exposure resulting in cell-mediated immunity [<a href=\"https://www.uptodate.com/contents/visceral-leishmaniasis-epidemiology-and-control/abstract/11,12,34,35\" class=\"abstract_t\">11,12,34,35</a>].</p><p>Transmission of <em>L. infantum</em> infection is considered zoonotic; the major reservoir is the domestic dog (<a href=\"image.htm?imageKey=ID%2F71680\" class=\"graphic graphic_figure graphicRef71680 \">figure 2</a>) [<a href=\"https://www.uptodate.com/contents/visceral-leishmaniasis-epidemiology-and-control/abstract/1,23,36\" class=\"abstract_t\">1,23,36</a>].</p><p class=\"headingAnchor\" id=\"H6\"><span class=\"h2\">Transmission</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>VL sand fly vectors include more than 10 species of the genus <em>Phlebotomus</em> (in the Old World) and <em>Lutzomyia longipalpis</em> (in the New World) [<a href=\"https://www.uptodate.com/contents/visceral-leishmaniasis-epidemiology-and-control/abstract/1,2\" class=\"abstract_t\">1,2</a>]. The female sand fly is hematophagous; both sexes take sugar meals from plant sources. Important sand fly characteristics that vary by species include breeding sites, peak feeding times, population seasonality, preferred blood meal sources, aggregation, and resting behavior [<a href=\"https://www.uptodate.com/contents/visceral-leishmaniasis-epidemiology-and-control/abstract/2,37\" class=\"abstract_t\">2,37</a>].</p><p>Leishmaniasis can also be transmitted via intravenous drug use, blood transfusion, organ transplantation, congenital infection, and laboratory accidents [<a href=\"https://www.uptodate.com/contents/visceral-leishmaniasis-epidemiology-and-control/abstract/38-43\" class=\"abstract_t\">38-43</a>]. These modes of transmission are rare.</p><p class=\"headingAnchor\" id=\"H7\"><span class=\"h1\">CONTROL</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Control of visceral leishmaniasis (VL) is based on two major approaches: vector control to decrease sand fly bites among humans and management of infected humans and animals to decrease the infection reservoir.</p><p class=\"headingAnchor\" id=\"H8\"><span class=\"h2\">Vector control</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Sand flies have a relatively limited flight range, and, in areas where transmission is predominantly sylvatic, it may be possible to establish vegetation-free buffer zones around human dwellings [<a href=\"https://www.uptodate.com/contents/visceral-leishmaniasis-epidemiology-and-control/abstract/44,45\" class=\"abstract_t\">44,45</a>]. In the major domestic transmission foci, interventions tend to focus on barrier methods such as bed nets and screens and insecticide application on surfaces where the flies rest. Thorough understanding of vector behavior is essential to design effective control strategies [<a href=\"https://www.uptodate.com/contents/visceral-leishmaniasis-epidemiology-and-control/abstract/44\" class=\"abstract_t\">44</a>]. Vector control modalities include indoor residual insecticide spraying (IRS), insecticide-treated nets (ITNs), and other applications of insecticides or repellents to decrease sand fly biting.</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>In areas where sand flies rest inside human dwellings, IRS every six months may be an effective intervention, although it is costly due to the infrastructure, equipment, and training required. Effective supervision is required to ensure the appropriate use of materials and to prevent diversion for agricultural applications. IRS conducted for malaria eradication in the Indian subcontinent during the 1950s and 1960s nearly eliminated VL, though a major resurgence occurred within a decade following the end of the program [<a href=\"https://www.uptodate.com/contents/visceral-leishmaniasis-epidemiology-and-control/abstract/46,47\" class=\"abstract_t\">46,47</a>]. Major efforts have been made to evaluate and improve IRS programs in the Indian subcontinent [<a href=\"https://www.uptodate.com/contents/visceral-leishmaniasis-epidemiology-and-control/abstract/48,49\" class=\"abstract_t\">48,49</a>]. (See <a href=\"topic.htm?path=malaria-epidemiology-prevention-and-control#H8\" class=\"medical medical_review\">&quot;Malaria: Epidemiology, prevention, and control&quot;, section on 'Indoor residual spraying'</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Insecticide-treated bed nets may be effective in regions such as South Asia, where the peak period of vector activity is late in the evening [<a href=\"https://www.uptodate.com/contents/visceral-leishmaniasis-epidemiology-and-control/abstract/50-52\" class=\"abstract_t\">50-52</a>]. However, a cluster-randomized trial of insecticide-treated nets failed to demonstrate a significant decrease in clinical VL and VL infection in sites in India and Nepal [<a href=\"https://www.uptodate.com/contents/visceral-leishmaniasis-epidemiology-and-control/abstract/53\" class=\"abstract_t\">53</a>], and decreases in indoor vector density were smaller than anticipated [<a href=\"https://www.uptodate.com/contents/visceral-leishmaniasis-epidemiology-and-control/abstract/54\" class=\"abstract_t\">54</a>]. Reasons for this failure are poorly understood but may be related to acquired insecticide resistance and changes in vector behavior (eg, from indoor to outdoor biting and resting) in response to insecticide pressure from poorly implemented indoor residual spray programs. Long-lasting insecticide-treated nets appear to maintain efficacy based on standard laboratory bioassays for at least two years under field conditions in South Asia [<a href=\"https://www.uptodate.com/contents/visceral-leishmaniasis-epidemiology-and-control/abstract/55\" class=\"abstract_t\">55</a>]. Limitations include the importance of regular use and that those at highest risk for VL are the least likely to obtain the materials successfully.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Treated dog collars are a promising tool for vector control in areas of zoonotic VL [<a href=\"https://www.uptodate.com/contents/visceral-leishmaniasis-epidemiology-and-control/abstract/56\" class=\"abstract_t\">56</a>].</p><p/><p>Use of insect repellent and insecticide-treated clothing is advisable for travelers [<a href=\"https://www.uptodate.com/contents/visceral-leishmaniasis-epidemiology-and-control/abstract/57\" class=\"abstract_t\">57</a>] but, in general, is not a practical routine intervention for residents of endemic areas. (See <a href=\"topic.htm?path=prevention-of-arthropod-and-insect-bites-repellents-and-other-measures\" class=\"medical medical_review\">&quot;Prevention of arthropod and insect bites: Repellents and other measures&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H9\"><span class=\"h2\">Reservoir hosts</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Rapid diagnosis and effective treatment of anthroponotic VL helps decrease the human reservoir of infection. Patients with post-kala-azar dermal leishmaniasis (PKDL) are an especially important reservoir of infection for a number of reasons; PKDL can persist for years, PKDL treatment requires a prolonged course of therapy, and such patients are less likely to seek care than those with kala-azar [<a href=\"https://www.uptodate.com/contents/visceral-leishmaniasis-epidemiology-and-control/abstract/58-60\" class=\"abstract_t\">58-60</a>]. Both VL and PKDL patients were shown to be infective to sand flies in xenodiagnosis studies conducted during the 1920s and 1930s [<a href=\"https://www.uptodate.com/contents/visceral-leishmaniasis-epidemiology-and-control/abstract/61,62\" class=\"abstract_t\">61,62</a>]. More recent studies confirm the infectivity of PKDL patients [<a href=\"https://www.uptodate.com/contents/visceral-leishmaniasis-epidemiology-and-control/abstract/63\" class=\"abstract_t\">63</a>]. Timely, improved diagnosis and treatment of PKDL will be essential to maintaining improved control of VL in India, Bangladesh, and Nepal [<a href=\"https://www.uptodate.com/contents/visceral-leishmaniasis-epidemiology-and-control/abstract/64\" class=\"abstract_t\">64</a>].</p><p>Programs focusing on reduction of canine reservoirs to decrease zoonotic VL transmission have not proved highly effective. This may be due to inadequate diagnostic sensitivity to identify infectious dogs, delay between diagnosis and culling, and the finding that most of the sand fly infections derive from a small percentage of highly infectious dogs (superspreaders) [<a href=\"https://www.uptodate.com/contents/visceral-leishmaniasis-epidemiology-and-control/abstract/65,66\" class=\"abstract_t\">65,66</a>]. Manipulations of animal populations may have unexpected consequences depending on host density and role (as infection reservoir, blood meal source for sand flies, <span class=\"nowrap\">and/or</span> nonsusceptible host) [<a href=\"https://www.uptodate.com/contents/visceral-leishmaniasis-epidemiology-and-control/abstract/2,61,67\" class=\"abstract_t\">2,61,67</a>].</p><p class=\"headingAnchor\" id=\"H10\"><span class=\"h1\">SUMMARY</span></p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Visceral leishmaniasis (VL) is caused primarily by the two related species <em>Leishmania donovani</em> and <em>Leishmania infantum</em> (synonym <em>Leishmania chagasi</em>). (See <a href=\"#H1\" class=\"local\">'Introduction'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>VL due to <em>L. infantum</em> (synonym <em>L. chagasi</em>) occurs in the Mediterranean, the Middle East, Afghanistan, Iran, Pakistan, and Brazil. In addition, sporadic cases have been reported in Central Asia, China, Mexico, and Central and Latin America outside of Brazil. In general, clinical disease due to <em>L. infantum</em> is more likely to occur in children &lt;10 years and immunosuppressed adults. <em>L. infantum</em> transmission is zoonotic; the major reservoir for <em>L. infantum</em> infection is the domestic dog. (See <a href=\"#H5\" class=\"local\">'L. infantum'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>VL due to <em>L. donovani</em> occurs in South Asia (India, Bangladesh, and Nepal) and the Horn of Africa (Sudan, Ethiopia, Kenya, and Somalia). Clinical disease due to <em>L. donovani</em> affects all ages, including otherwise healthy adults. In the Indian subcontinent, <em>L. donovani</em> transmission is anthroponotic; humans are the only proven reservoir host. In East Africa, both anthroponotic and zoonotic <em>L. donovani</em> transmission occur. (See <a href=\"#H4\" class=\"local\">'L. donovani'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>VL sand fly vectors include more than 90 species of the genus <em>Phlebotomus</em> (in the Old World) and <em>Lutzomyia longipalpis</em> (in the New World). VL can also be transmitted via intravenous drug use, blood transfusion, organ transplantation, congenital infection, and laboratory accidents; these modes of transmission are rare. (See <a href=\"#H6\" class=\"local\">'Transmission'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Control of VL is based on two major approaches: vector control to decrease sand fly bites among humans and management of infected humans and animals to decrease the infection reservoir. (See <a href=\"#H7\" class=\"local\">'Control'</a> above.)</p><p/></div><div id=\"topicAgreement\">Use of UpToDate is subject to the <a href=\"https://www.uptodate.com/legal/license\" class=\"licenseLink\" id=\"sla_in_page\">Subscription and License Agreement</a>.</div><div id=\"references\" class=\"headingAnchor\"><h1>REFERENCES</h1><ol id=\"reference\"><li class=\"breakAll\">Jeronimo SMB, de Queiroz Sousa A, Pearson RD. Leishmaniasis. In: Tropical Infectious Diseases: Principles, Pathogens and Practice, 3rd ed, Guerrant RL, Walker DH, Weller PF (Eds), Saunders Elsevier, Philadelphia 2011. p.696.</li><li><a href=\"https://www.uptodate.com/contents/visceral-leishmaniasis-epidemiology-and-control/abstract/2\" class=\"nounderline abstract_t\">World Health Organization. Control of the Leishmaniases: Report of the WHO Expert Committee Meeting, Geneva. March 22-26, 2010. WHO Technical Report Series 2010; 949:1.</a></li><li class=\"breakAll\">World Health Organization. The Global Burden of Disease: 2004 update. Geneva, Switzerland: World Health Organization, 2008.</li><li><a href=\"https://www.uptodate.com/contents/visceral-leishmaniasis-epidemiology-and-control/abstract/4\" class=\"nounderline abstract_t\">Alvar J, V&eacute;lez ID, Bern C, et al. Leishmaniasis worldwide and global estimates of its incidence. PLoS One 2012; 7:e35671.</a></li><li><a href=\"https://www.uptodate.com/contents/visceral-leishmaniasis-epidemiology-and-control/abstract/5\" class=\"nounderline abstract_t\">Mathers CD, Ezzati M, Lopez AD. Measuring the burden of neglected tropical diseases: the global burden of disease framework. PLoS Negl Trop Dis 2007; 1:e114.</a></li><li><a href=\"https://www.uptodate.com/contents/visceral-leishmaniasis-epidemiology-and-control/abstract/6\" class=\"nounderline abstract_t\">Yamey G, Torreele E. The world's most neglected diseases. BMJ 2002; 325:176.</a></li><li><a href=\"https://www.uptodate.com/contents/visceral-leishmaniasis-epidemiology-and-control/abstract/7\" class=\"nounderline abstract_t\">Alvar J, Yactayo S, Bern C. Leishmaniasis and poverty. Trends Parasitol 2006; 22:552.</a></li><li><a href=\"https://www.uptodate.com/contents/visceral-leishmaniasis-epidemiology-and-control/abstract/8\" class=\"nounderline abstract_t\">Marty P, Lelievre A, Quaranta JF, et al. Use of the leishmanin skin test and western blot analysis for epidemiological studies in visceral leishmaniasis areas: experience in a highly endemic focus in Alpes-Maritimes (France). Trans R Soc Trop Med Hyg 1994; 88:658.</a></li><li><a href=\"https://www.uptodate.com/contents/visceral-leishmaniasis-epidemiology-and-control/abstract/9\" class=\"nounderline abstract_t\">Hasker E, Malaviya P, Gidwani K, et al. Strong association between serological status and probability of progression to clinical visceral leishmaniasis in prospective cohort studies in India and Nepal. PLoS Negl Trop Dis 2014; 8:e2657.</a></li><li><a href=\"https://www.uptodate.com/contents/visceral-leishmaniasis-epidemiology-and-control/abstract/10\" class=\"nounderline abstract_t\">Bern C, Haque R, Chowdhury R, et al. The epidemiology of visceral leishmaniasis and asymptomatic leishmanial infection in a highly endemic Bangladeshi village. Am J Trop Med Hyg 2007; 76:909.</a></li><li><a href=\"https://www.uptodate.com/contents/visceral-leishmaniasis-epidemiology-and-control/abstract/11\" class=\"nounderline abstract_t\">Lima ID, Queiroz JW, Lacerda HG, et al. Leishmania infantum chagasi in northeastern Brazil: asymptomatic infection at the urban perimeter. Am J Trop Med Hyg 2012; 86:99.</a></li><li><a href=\"https://www.uptodate.com/contents/visceral-leishmaniasis-epidemiology-and-control/abstract/12\" class=\"nounderline abstract_t\">Bern C, Amann J, Haque R, et al. Loss of leishmanin skin test antigen sensitivity and potency in a longitudinal study of visceral leishmaniasis in Bangladesh. Am J Trop Med Hyg 2006; 75:744.</a></li><li><a href=\"https://www.uptodate.com/contents/visceral-leishmaniasis-epidemiology-and-control/abstract/13\" class=\"nounderline abstract_t\">Davies CR, Mazloumi Gavgani AS. Age, acquired immunity and the risk of visceral leishmaniasis: a prospective study in Iran. Parasitology 1999; 119 ( Pt 3):247.</a></li><li><a href=\"https://www.uptodate.com/contents/visceral-leishmaniasis-epidemiology-and-control/abstract/14\" class=\"nounderline abstract_t\">Khalil EA, Zijlstra EE, Kager PA, El Hassan AM. Epidemiology and clinical manifestations of Leishmania donovani infection in two villages in an endemic area in eastern Sudan. Trop Med Int Health 2002; 7:35.</a></li><li><a href=\"https://www.uptodate.com/contents/visceral-leishmaniasis-epidemiology-and-control/abstract/15\" class=\"nounderline abstract_t\">Alvar J, Bashaye S, Argaw D, et al. Kala-azar outbreak in Libo Kemkem, Ethiopia: epidemiologic and parasitologic assessment. Am J Trop Med Hyg 2007; 77:275.</a></li><li><a href=\"https://www.uptodate.com/contents/visceral-leishmaniasis-epidemiology-and-control/abstract/16\" class=\"nounderline abstract_t\">Cerf BJ, Jones TC, Badaro R, et al. Malnutrition as a risk factor for severe visceral leishmaniasis. J Infect Dis 1987; 156:1030.</a></li><li><a href=\"https://www.uptodate.com/contents/visceral-leishmaniasis-epidemiology-and-control/abstract/17\" class=\"nounderline abstract_t\">Anstead GM, Chandrasekar B, Zhao W, et al. Malnutrition alters the innate immune response and increases early visceralization following Leishmania donovani infection. Infect Immun 2001; 69:4709.</a></li><li><a href=\"https://www.uptodate.com/contents/visceral-leishmaniasis-epidemiology-and-control/abstract/18\" class=\"nounderline abstract_t\">Soong L, Henard CA, Melby PC. Immunopathogenesis of non-healing American cutaneous leishmaniasis and progressive visceral leishmaniasis. Semin Immunopathol 2012; 34:735.</a></li><li><a href=\"https://www.uptodate.com/contents/visceral-leishmaniasis-epidemiology-and-control/abstract/19\" class=\"nounderline abstract_t\">Jeronimo SM, Duggal P, Ettinger NA, et al. Genetic predisposition to self-curing infection with the protozoan Leishmania chagasi: a genomewide scan. J Infect Dis 2007; 196:1261.</a></li><li><a href=\"https://www.uptodate.com/contents/visceral-leishmaniasis-epidemiology-and-control/abstract/20\" class=\"nounderline abstract_t\">van Griensven J, Carrillo E, L&oacute;pez-V&eacute;lez R, et al. Leishmaniasis in immunosuppressed individuals. Clin Microbiol Infect 2014; 20:286.</a></li><li><a href=\"https://www.uptodate.com/contents/visceral-leishmaniasis-epidemiology-and-control/abstract/21\" class=\"nounderline abstract_t\">Leishmaniasis in high-burden countries: an epidemiological update based on data reported in 2014. Wkly Epidemiol Rec 2016; 91:287.</a></li><li class=\"breakAll\">World Health Organization. Leishmaniasis: Country profiles. http://www.who.int/leishmaniasis/burden/Country_profiles/en/ (Accessed on May 08, 2017).</li><li><a href=\"https://www.uptodate.com/contents/visceral-leishmaniasis-epidemiology-and-control/abstract/23\" class=\"nounderline abstract_t\">Bern C, Maguire JH, Alvar J. Complexities of assessing the disease burden attributable to leishmaniasis. PLoS Negl Trop Dis 2008; 2:e313.</a></li><li><a href=\"https://www.uptodate.com/contents/visceral-leishmaniasis-epidemiology-and-control/abstract/24\" class=\"nounderline abstract_t\">Singh N, Mishra J, Singh R, Singh S. Animal reservoirs of visceral leishmaniasis in India. J Parasitol 2013; 99:64.</a></li><li><a href=\"https://www.uptodate.com/contents/visceral-leishmaniasis-epidemiology-and-control/abstract/25\" class=\"nounderline abstract_t\">Elnaiem DA, Hassan HK, Ward RD. Phlebotomine sandflies in a focus of visceral leishmaniasis in a border area of eastern Sudan. Ann Trop Med Parasitol 1997; 91:307.</a></li><li><a href=\"https://www.uptodate.com/contents/visceral-leishmaniasis-epidemiology-and-control/abstract/26\" class=\"nounderline abstract_t\">Bucheton B, Kheir MM, El-Safi SH, et al. The interplay between environmental and host factors during an outbreak of visceral leishmaniasis in eastern Sudan. Microbes Infect 2002; 4:1449.</a></li><li><a href=\"https://www.uptodate.com/contents/visceral-leishmaniasis-epidemiology-and-control/abstract/27\" class=\"nounderline abstract_t\">Seaman J, Mercer AJ, Sondorp E. The epidemic of visceral leishmaniasis in western Upper Nile, southern Sudan: course and impact from 1984 to 1994. Int J Epidemiol 1996; 25:862.</a></li><li><a href=\"https://www.uptodate.com/contents/visceral-leishmaniasis-epidemiology-and-control/abstract/28\" class=\"nounderline abstract_t\">Elnaiem DA, Hassan MM, Maingon R, et al. The Egyptian mongoose, Herpestes ichneumon, is a possible reservoir host of visceral leishmaniasis in eastern Sudan. Parasitology 2001; 122:531.</a></li><li><a href=\"https://www.uptodate.com/contents/visceral-leishmaniasis-epidemiology-and-control/abstract/29\" class=\"nounderline abstract_t\">Dereure J, El-Safi SH, Bucheton B, et al. Visceral leishmaniasis in eastern Sudan: parasite identification in humans and dogs; host-parasite relationships. Microbes Infect 2003; 5:1103.</a></li><li><a href=\"https://www.uptodate.com/contents/visceral-leishmaniasis-epidemiology-and-control/abstract/30\" class=\"nounderline abstract_t\">Evans TG, Teixeira MJ, McAuliffe IT, et al. Epidemiology of visceral leishmaniasis in northeast Brazil. J Infect Dis 1992; 166:1124.</a></li><li><a href=\"https://www.uptodate.com/contents/visceral-leishmaniasis-epidemiology-and-control/abstract/31\" class=\"nounderline abstract_t\">Alvar J, Aparicio P, Aseffa A, et al. The relationship between leishmaniasis and AIDS: the second 10 years. Clin Microbiol Rev 2008; 21:334.</a></li><li><a href=\"https://www.uptodate.com/contents/visceral-leishmaniasis-epidemiology-and-control/abstract/32\" class=\"nounderline abstract_t\">Gil-Prieto R, Walter S, Alvar J, de Miguel AG. Epidemiology of leishmaniasis in Spain based on hospitalization records (1997-2008). Am J Trop Med Hyg 2011; 85:820.</a></li><li><a href=\"https://www.uptodate.com/contents/visceral-leishmaniasis-epidemiology-and-control/abstract/33\" class=\"nounderline abstract_t\">Dye C, Williams BG. Malnutrition, age and the risk of parasitic disease: visceral leishmaniasis revisited. Proc Biol Sci 1993; 254:33.</a></li><li><a href=\"https://www.uptodate.com/contents/visceral-leishmaniasis-epidemiology-and-control/abstract/34\" class=\"nounderline abstract_t\">Seaman J, Ashford RW, Schorscher J, Dereure J. Visceral leishmaniasis in southern Sudan: status of healthy villagers in epidemic conditions. Ann Trop Med Parasitol 1992; 86:481.</a></li><li><a href=\"https://www.uptodate.com/contents/visceral-leishmaniasis-epidemiology-and-control/abstract/35\" class=\"nounderline abstract_t\">Gramiccia M, Bettini S, Gradoni L, et al. Leishmaniasis in Sardinia. 5. Leishmanin reaction in the human population of a focus of low endemicity of canine leishmaniasis. Trans R Soc Trop Med Hyg 1990; 84:371.</a></li><li><a href=\"https://www.uptodate.com/contents/visceral-leishmaniasis-epidemiology-and-control/abstract/36\" class=\"nounderline abstract_t\">Courtenay O, Quinnell RJ, Garcez LM, Dye C. Low infectiousness of a wildlife host of Leishmania infantum: the crab-eating fox is not important for transmission. Parasitology 2002; 125:407.</a></li><li><a href=\"https://www.uptodate.com/contents/visceral-leishmaniasis-epidemiology-and-control/abstract/37\" class=\"nounderline abstract_t\">Alexander B, Maroli M. Control of phlebotomine sandflies. Med Vet Entomol 2003; 17:1.</a></li><li><a href=\"https://www.uptodate.com/contents/visceral-leishmaniasis-epidemiology-and-control/abstract/38\" class=\"nounderline abstract_t\">Dey A, Singh S. Transfusion transmitted leishmaniasis: a case report and review of literature. Indian J Med Microbiol 2006; 24:165.</a></li><li><a href=\"https://www.uptodate.com/contents/visceral-leishmaniasis-epidemiology-and-control/abstract/39\" class=\"nounderline abstract_t\">Antinori S, Cascio A, Parravicini C, et al. Leishmaniasis among organ transplant recipients. Lancet Infect Dis 2008; 8:191.</a></li><li><a href=\"https://www.uptodate.com/contents/visceral-leishmaniasis-epidemiology-and-control/abstract/40\" class=\"nounderline abstract_t\">Herwaldt BL, Juranek DD. Laboratory-acquired malaria, leishmaniasis, trypanosomiasis, and toxoplasmosis. Am J Trop Med Hyg 1993; 48:313.</a></li><li><a href=\"https://www.uptodate.com/contents/visceral-leishmaniasis-epidemiology-and-control/abstract/41\" class=\"nounderline abstract_t\">Meinecke CK, Schottelius J, Oskam L, Fleischer B. Congenital transmission of visceral leishmaniasis (Kala Azar) from an asymptomatic mother to her child. Pediatrics 1999; 104:e65.</a></li><li><a href=\"https://www.uptodate.com/contents/visceral-leishmaniasis-epidemiology-and-control/abstract/42\" class=\"nounderline abstract_t\">Alvar J, Jim&eacute;nez M. Could infected drug-users be potential Leishmania infantum reservoirs? AIDS 1994; 8:854.</a></li><li><a href=\"https://www.uptodate.com/contents/visceral-leishmaniasis-epidemiology-and-control/abstract/43\" class=\"nounderline abstract_t\">Cruz I, Morales MA, Noguer I, et al. Leishmania in discarded syringes from intravenous drug users. Lancet 2002; 359:1124.</a></li><li><a href=\"https://www.uptodate.com/contents/visceral-leishmaniasis-epidemiology-and-control/abstract/44\" class=\"nounderline abstract_t\">Bates PA, Depaquit J, Galati EA, et al. Recent advances in phlebotomine sand fly research related to leishmaniasis control. Parasit Vectors 2015; 8:131.</a></li><li><a href=\"https://www.uptodate.com/contents/visceral-leishmaniasis-epidemiology-and-control/abstract/45\" class=\"nounderline abstract_t\">Killick-Kendrick R, Rioux JA, Bailly M, et al. Ecology of leishmaniasis in the south of France. 20. Dispersal of Phlebotomus ariasi Tonnoir, 1921 as a factor in the spread of visceral leishmaniasis in the C&eacute;vennes. Ann Parasitol Hum Comp 1984; 59:555.</a></li><li><a href=\"https://www.uptodate.com/contents/visceral-leishmaniasis-epidemiology-and-control/abstract/46\" class=\"nounderline abstract_t\">Bora D. Epidemiology of visceral leishmaniasis in India. Natl Med J India 1999; 12:62.</a></li><li><a href=\"https://www.uptodate.com/contents/visceral-leishmaniasis-epidemiology-and-control/abstract/47\" class=\"nounderline abstract_t\">Sen Gupta PC. Return of kala-azar. J Indian Med Assoc 1975; 65:89.</a></li><li><a href=\"https://www.uptodate.com/contents/visceral-leishmaniasis-epidemiology-and-control/abstract/48\" class=\"nounderline abstract_t\">Chowdhury R, Huda MM, Kumar V, et al. The Indian and Nepalese programmes of indoor residual spraying for the elimination of visceral leishmaniasis: performance and effectiveness. Ann Trop Med Parasitol 2011; 105:31.</a></li><li><a href=\"https://www.uptodate.com/contents/visceral-leishmaniasis-epidemiology-and-control/abstract/49\" class=\"nounderline abstract_t\">Coleman M, Foster GM, Deb R, et al. DDT-based indoor residual spraying suboptimal for visceral leishmaniasis elimination in India. Proc Natl Acad Sci U S A 2015; 112:8573.</a></li><li><a href=\"https://www.uptodate.com/contents/visceral-leishmaniasis-epidemiology-and-control/abstract/50\" class=\"nounderline abstract_t\">Reyburn H, Ashford R, Mohsen M, et al. A randomized controlled trial of insecticide-treated bednets and chaddars or top sheets, and residual spraying of interior rooms for the prevention of cutaneous leishmaniasis in Kabul, Afghanistan. Trans R Soc Trop Med Hyg 2000; 94:361.</a></li><li><a href=\"https://www.uptodate.com/contents/visceral-leishmaniasis-epidemiology-and-control/abstract/51\" class=\"nounderline abstract_t\">Courtenay O, Gillingwater K, Gomes PA, et al. Deltamethrin-impregnated bednets reduce human landing rates of sandfly vector Lutzomyia longipalpis in Amazon households. Med Vet Entomol 2007; 21:168.</a></li><li><a href=\"https://www.uptodate.com/contents/visceral-leishmaniasis-epidemiology-and-control/abstract/52\" class=\"nounderline abstract_t\">Mondal D, Huda MM, Karmoker MK, et al. Reducing visceral leishmaniasis by insecticide impregnation of bed-nets, Bangladesh. Emerg Infect Dis 2013; 19:1131.</a></li><li><a href=\"https://www.uptodate.com/contents/visceral-leishmaniasis-epidemiology-and-control/abstract/53\" class=\"nounderline abstract_t\">Picado A, Singh SP, Rijal S, et al. Longlasting insecticidal nets for prevention of Leishmania donovani infection in India and Nepal: paired cluster randomised trial. BMJ 2010; 341:c6760.</a></li><li><a href=\"https://www.uptodate.com/contents/visceral-leishmaniasis-epidemiology-and-control/abstract/54\" class=\"nounderline abstract_t\">Dinesh DS, Das P, Picado A, et al. Long-lasting insecticidal nets fail at household level to reduce abundance of sandfly vector Phlebotomus argentipes in treated houses in Bihar (India). Trop Med Int Health 2008; 13:953.</a></li><li><a href=\"https://www.uptodate.com/contents/visceral-leishmaniasis-epidemiology-and-control/abstract/55\" class=\"nounderline abstract_t\">Picado A, Singh SP, Vanlerberghe V, et al. Residual activity and integrity of PermaNet&reg; 2.0 after 24 months of household use in a community randomised trial of long lasting insecticidal nets against visceral leishmaniasis in India and Nepal. Trans R Soc Trop Med Hyg 2012; 106:150.</a></li><li><a href=\"https://www.uptodate.com/contents/visceral-leishmaniasis-epidemiology-and-control/abstract/56\" class=\"nounderline abstract_t\">Gavgani AS, Hodjati MH, Mohite H, Davies CR. Effect of insecticide-impregnated dog collars on incidence of zoonotic visceral leishmaniasis in Iranian children: a matched-cluster randomised trial. Lancet 2002; 360:374.</a></li><li><a href=\"https://www.uptodate.com/contents/visceral-leishmaniasis-epidemiology-and-control/abstract/57\" class=\"nounderline abstract_t\">Schreck CE, Kline DL, Chaniotis BN, et al. Evaluation of personal protection methods against phlebotomine sand flies including vectors of leishmaniasis in Panama. Am J Trop Med Hyg 1982; 31:1046.</a></li><li><a href=\"https://www.uptodate.com/contents/visceral-leishmaniasis-epidemiology-and-control/abstract/58\" class=\"nounderline abstract_t\">Addy M, Nandy A. Ten years of kala-azar in west Bengal, Part I. Did post-kala-azar dermal leishmaniasis initiate the outbreak in 24-Parganas? Bull World Health Organ 1992; 70:341.</a></li><li><a href=\"https://www.uptodate.com/contents/visceral-leishmaniasis-epidemiology-and-control/abstract/59\" class=\"nounderline abstract_t\">Napier LE, Das Gupta CR. An epidemiological investigation of kala-azar in a rural area in Bengal. Indian J Med Res 1931; 19:295.</a></li><li><a href=\"https://www.uptodate.com/contents/visceral-leishmaniasis-epidemiology-and-control/abstract/60\" class=\"nounderline abstract_t\">Islam S, Kenah E, Bhuiyan MA, et al. Clinical and immunological aspects of post-kala-azar dermal leishmaniasis in Bangladesh. Am J Trop Med Hyg 2013; 89:345.</a></li><li><a href=\"https://www.uptodate.com/contents/visceral-leishmaniasis-epidemiology-and-control/abstract/61\" class=\"nounderline abstract_t\">Quinnell RJ, Courtenay O. Transmission, reservoir hosts and control of zoonotic visceral leishmaniasis. Parasitology 2009; 136:1915.</a></li><li><a href=\"https://www.uptodate.com/contents/visceral-leishmaniasis-epidemiology-and-control/abstract/62\" class=\"nounderline abstract_t\">Killick-Kendrick R. The race to discover the insect vector of kala-azar: a great saga of tropical medicine 1903-1942. Bull Soc Pathol Exot 2013; 106:131.</a></li><li><a href=\"https://www.uptodate.com/contents/visceral-leishmaniasis-epidemiology-and-control/abstract/63\" class=\"nounderline abstract_t\">Molina R, Ghosh D, Carrillo E, et al. Infectivity of Post-Kala-azar Dermal Leishmaniasis Patients to Sand Flies: Revisiting a Proof of Concept in the Context of the Kala-azar Elimination Program in the Indian Subcontinent. Clin Infect Dis 2017; 65:150.</a></li><li><a href=\"https://www.uptodate.com/contents/visceral-leishmaniasis-epidemiology-and-control/abstract/64\" class=\"nounderline abstract_t\">Cameron MM, Acosta-Serrano A, Bern C, et al. Understanding the transmission dynamics of Leishmania donovani to provide robust evidence for interventions to eliminate visceral leishmaniasis in Bihar, India. Parasit Vectors 2016; 9:25.</a></li><li><a href=\"https://www.uptodate.com/contents/visceral-leishmaniasis-epidemiology-and-control/abstract/65\" class=\"nounderline abstract_t\">Courtenay O, Quinnell RJ, Garcez LM, et al. Infectiousness in a cohort of brazilian dogs: why culling fails to control visceral leishmaniasis in areas of high transmission. J Infect Dis 2002; 186:1314.</a></li><li><a href=\"https://www.uptodate.com/contents/visceral-leishmaniasis-epidemiology-and-control/abstract/66\" class=\"nounderline abstract_t\">Courtenay O, Carson C, Calvo-Bado L, et al. Heterogeneities in Leishmania infantum infection: using skin parasite burdens to identify highly infectious dogs. PLoS Negl Trop Dis 2014; 8:e2583.</a></li><li><a href=\"https://www.uptodate.com/contents/visceral-leishmaniasis-epidemiology-and-control/abstract/67\" class=\"nounderline abstract_t\">Bern C, Courtenay O, Alvar J. Of cattle, sand flies and men: a systematic review of risk factor analyses for South Asian visceral leishmaniasis and implications for elimination. PLoS Negl Trop Dis 2010; 4:e599.</a></li></ol></div><div id=\"topicVersionRevision\">Topic 5690 Version 16.0</div></div>","outline":"<div id=\"outlineSections\"><h2>Topic Outline</h2><ul id=\"innerOutline\"><li class=\"sr-button\"><a href=\"#H10\"><span>SUMMARY</span></a></li><li><a href=\"#H1\" id=\"outline-link-H1\">INTRODUCTION</a></li><li><a href=\"#H2\" id=\"outline-link-H2\">EPIDEMIOLOGY</a><ul><li><a href=\"#H3\" id=\"outline-link-H3\">Species</a><ul><li><a href=\"#H4\" id=\"outline-link-H4\">- L. donovani</a></li><li><a href=\"#H5\" id=\"outline-link-H5\">- L. infantum</a></li></ul></li><li><a href=\"#H6\" id=\"outline-link-H6\">Transmission</a></li></ul></li><li><a href=\"#H7\" id=\"outline-link-H7\">CONTROL</a><ul><li><a href=\"#H8\" id=\"outline-link-H8\">Vector control</a></li><li><a href=\"#H9\" id=\"outline-link-H9\">Reservoir hosts</a></li></ul></li><li><a href=\"#H10\" id=\"outline-link-H10\">SUMMARY</a></li><li><a href=\"#references\">REFERENCES</a></li></ul></div><div><h2>GRAPHICS <a href=\"#\" id=\"viewAllGraphicsLink\">View All</a></h2><div id=\"outlineGraphics\"><ul><li><div id=\"ID/5690|FIG\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"FIGURES\">FIGURES</a></div><ul><li><a href=\"image.htm?imageKey=ID/110870\" class=\"graphic graphic_figure\">- Map - visceral leishmaniasis</a></li><li><a href=\"image.htm?imageKey=ID/71680\" class=\"graphic graphic_figure\">- Leishmania life cycle</a></li></ul></li><li><div id=\"ID/5690|TAB\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"TABLES\">TABLES</a></div><ul><li><a href=\"image.htm?imageKey=ID/58861\" class=\"graphic graphic_table\">- Leishmaniasis species</a></li></ul></li></ul></div></div><div><h2>RELATED TOPICS</h2><div id=\"outlineTopics\"><ul><li class=\"plainItem\"><a href=\"topic.htm?path=malaria-epidemiology-prevention-and-control\" class=\"medical medical_review\">Malaria: Epidemiology, prevention, and control</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=prevention-of-arthropod-and-insect-bites-repellents-and-other-measures\" class=\"medical medical_review\">Prevention of arthropod and insect bites: Repellents and other measures</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=visceral-leishmaniasis-clinical-manifestations-and-diagnosis\" class=\"medical medical_review\">Visceral leishmaniasis: Clinical manifestations and diagnosis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=visceral-leishmaniasis-treatment\" class=\"medical medical_review\">Visceral leishmaniasis: Treatment</a></li></ul></div></div>","javascript":null}